Chinese humanoid robot maker Unitree has attracted extraordinary investor interest ahead of its planned Shanghai stock market listing, with its retail share offering initially oversubscribed more than 5,500 times.
The company is seeking to raise about $900 million through the initial public offering, which would value Unitree at roughly $9 billion.
Unitree is offering 40.4 million shares at 150.80 yuan each, representing about 10 percent of its enlarged share capital. The offering has become a major test of investor appetite for Chinas rapidly developing robotics industry.
The reported oversubscription means retail investors sought allocations worth thousands of times more than the number of shares available to them.
Subsequent demand pushed the reported oversubscription even higher, above 8,000 times according to a company filing reported by Reuters.
Unitree has become one of Chinas most recognisable robotics companies, particularly through demonstrations of humanoid and quadruped robots.
The company was founded by Wang Xingxing and is based in Hangzhou. It initially became known for quadruped robots before expanding into humanoid machines designed for research, industrial and other applications.
Unitrees growing profile reflects Chinas wider push into embodied artificial intelligence, where machines are designed to perceive their surroundings, make decisions and physically interact with the world.
The company plans to use about 2 billion yuan from the IPO proceeds to develop artificial intelligence models for its robots, alongside research and development and other expansion activities.
The enthusiasm surrounding the listing is also part of a broader surge in Chinese technology stocks. The technology-heavy Star 50 index has risen strongly this year as investors have increased their exposure to artificial intelligence and other emerging technologies.
Unitrees valuation, however, raises questions about how much future growth investors are already pricing into the company.
At the IPO price, the company is valued at more than 60 billion yuan. Reuters reported that this represents about 219 times its projected 2025 earnings, highlighting the exceptionally high expectations surrounding the robotics sector.
The company is entering a market where competition is intensifying rapidly. Chinese robotics companies are racing to develop machines capable of performing increasingly complex physical tasks, while international companies including Tesla and Boston Dynamics are pursuing similar technologies.
Unitree has also attracted international attention through its overseas sales and demonstrations. Its robots have been used in research and commercial settings, helping the company establish a presence beyond China.
Commercialising humanoid robots remains a major challenge. Demonstrating that a robot can walk, dance or perform controlled movements is very different from deploying machines reliably and economically in factories, warehouses, homes or other demanding environments.
The technology therefore remains at an early stage of commercial development, even as investor expectations rise sharply.
Unitree has also faced geopolitical risks. The United States recently restricted imports of new foreign-made humanoid and quadruped robots, creating potential complications for Chinese manufacturers seeking to expand in the American market.
Unitree has said its existing sales in the United States would not be affected by the restrictions, although future products could face greater obstacles.
The IPO nevertheless demonstrates the scale of investor enthusiasm surrounding humanoid robotics in China. Nearly 10 million retail investors were reported to have participated in the offering, contributing to the extraordinary level of oversubscription.
The company is expected to become Chinas first listed humanoid robotics manufacturer, giving investors a publicly traded vehicle through which to gain exposure to the countrys rapidly developing robotics industry.
For Unitree, the challenge after the listing will be turning technological demonstrations and investor enthusiasm into sustained commercial growth.
For Chinas robotics industry, the IPO represents something larger. It shows how quickly humanoid robots have moved from experimental machines and technology demonstrations into one of the countrys most closely watched investment themes.
The extraordinary subscription figures therefore tell two stories at once. Investors are betting heavily on the future of humanoid robotics, while Unitree now faces the much harder task of proving that the technology can justify those expectations.
Comments (0)
Leave a Comment
No comments yet. Be the first to share your thoughts!